| Source: |
| Type: |
| Power to enhance an anti cancer effect |
| 3220- | EGCG, | Dual Roles of Nrf2 in Cancer |
| - | in-vitro, | Lung, | A549 |
| 3241- | EGCG, | Epigallocatechin gallate triggers apoptosis by suppressing de novo lipogenesis in colorectal carcinoma cells |
| - | in-vitro, | CRC, | HCT116 | - | in-vitro, | CRC, | HT29 | - | in-vitro, | Liver, | HepG2 | - | in-vitro, | Liver, | HUH7 |
| 3215- | EGCG, | Epigallocatechin gallate modulates ferroptosis through downregulation of tsRNA-13502 in non-small cell lung cancer |
| - | in-vitro, | NSCLC, | A549 | - | in-vitro, | NSCLC, | H1299 |
| 3202- | EGCG, | Epigallocatechin-3-gallate enhances ER stress-induced cancer cell apoptosis by directly targeting PARP16 activity |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | HCC, | QGY-7703 |
| 3205- | EGCG, | The Role of Epigallocatechin-3-Gallate in Autophagy and Endoplasmic Reticulum Stress (ERS)-Induced Apoptosis of Human Diseas |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 3212- | EGCG, | EGCG maintained Nrf2-mediated redox homeostasis and minimized etoposide resistance in lung cancer cells |
| - | in-vitro, | Lung, | A549 | - | in-vivo, | Lung, | NCIH23 |
| 1514- | EGCG, | Preferential inhibition by (-)-epigallocatechin-3-gallate of the cell surface NADH oxidase and growth of transformed cells in culture |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | Nor, | MCF10 |
| 1503- | EGCG, | Epigenetic targets of bioactive dietary components for cancer prevention and therapy |
| - | Review, | NA, | NA |
| 1516- | EGCG, | Epigallocatechin Gallate (EGCG): Pharmacological Properties, Biological Activities and Therapeutic Potential |
| - | Review, | NA, | NA |
| 1515- | EGCG, | Phen, | Reciprocal Relationship Between Cytosolic NADH and ENOX2 Inhibition Triggers Sphingolipid-Induced Apoptosis in HeLa Cells |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | Nor, | MCF10 | - | in-vitro, | BC, | BT20 |
| 2309- | EGCG, | Chemo, | Targeting Glycolysis with Epigallocatechin-3-Gallate Enhances the Efficacy of Chemotherapeutics in Pancreatic Cancer Cells and Xenografts |
| - | in-vitro, | PC, | MIA PaCa-2 | - | in-vitro, | Nor, | HPNE | - | in-vitro, | PC, | PANC1 | - | in-vivo, | NA, | NA |
| 2501- | EGCG, | A Case of Complete and Durable Molecular Remission of Chronic Lymphocytic Leukemia Following Treatment with Epigallocatechin-3-gallate, an Extract of Green Tea |
| - | Case Report, | AML, | NA |
| 2563- | EGCG, | Cardioprotective effect of epigallocatechin gallate in myocardial ischemia/reperfusion injury and myocardial infarction: a meta-analysis in preclinical animal studies |
| - | Review, | NA, | NA |
| 2561- | EGCG, | ASA, | Anti-platelet effects of epigallocatechin-3-gallate in addition to the concomitant aspirin, clopidogrel or ticagrelor treatment |
| - | ex-vivo, | Nor, | NA |
| 5931- | EGCG, | BTZ, | EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism |
| - | in-vitro, | Pca, | PC3 |
| 1322- | EMD, | The versatile emodin: A natural easily acquired anthraquinone possesses promising anticancer properties against a variety of cancers |
| - | Review, | Var, | NA |
| 1329- | EMD, | Aloe-emodin induces cell death through S-phase arrest and caspase-dependent pathways in human tongue squamous cancer SCC-4 cells |
| - | in-vitro, | Tong, | SCC4 |
| 5530- | EP, | Expression of voltage-gated calcium channels augments cell susceptibility to membrane disruption by nanosecond pulsed electric field |
| - | in-vitro, | Nor, | HEK293 |
| 5487- | EP, | High-frequency irreversible electroporation improves survival and immune cell infiltration in rodents with malignant gliomas |
| - | in-vivo, | GBM, | NA |
| 5488- | EP, | An in vivo study of a custom-made high-frequency irreversible electroporation generator on different tissues for clinically relevant ablation zones |
| - | in-vivo, | Nor, | NA |
| 5489- | EP, | Electroporation and cell killing by milli- to nanosecond pulses and avoiding neuromuscular stimulation in cancer ablation |
| - | in-vitro, | Colon, | NA |
| 5491- | EP, | Nano-pulse stimulation™ therapy (NPS™) is superior to cryoablation in clearing murine melanoma tumors |
| - | in-vivo, | Melanoma, | B16-F10 |
| 5492- | EP, | Nano-Pulse Stimulation Therapy in Oncology |
| - | in-vivo, | PC, | Panc02 | - | in-vivo, | BC, | 4T1 |
| 5519- | EP, | Nanosecond Pulsed Electric Fields (nsPEFs) for Precision Intracellular Oncotherapy: Recent Advances and Emerging Directions |
| - | Review, | Var, | NA |
| 5047- | erastin, | The ferroptosis inducer erastin irreversibly inhibits system xc− and synergizes with cisplatin to increase cisplatin’s cytotoxicity in cancer cells |
| - | in-vitro, | Ovarian, | NA |
| 2204- | erastin, | Regulation of ferroptotic cancer cell death by GPX4 |
| - | in-vitro, | fibroS, | HT1080 |
| 2144- | Ex, | Physical activity, hormone replacement therapy and breast cancer risk: A meta-analysis of prospective studies |
| - | Analysis, | NA, | NA |
| 2145- | Ex, | Leisure time physical activity and cancer risk: evaluation of the WHO's recommendation based on 126 high-quality epidemiological studies |
| - | Analysis, | Var, | NA |
| 2146- | Ex, | A systematic review and meta-analysis of physical activity and endometrial cancer risk |
| - | Review, | Endo, | NA |
| 2153- | Ex, | The Impact of Exercise on Cancer Mortality, Recurrence, and Treatment-Related Adverse Effects |
| - | Review, | Var, | NA |
| 2151- | Ex, | The effects of physical activity on overall survival among advanced cancer patients: a systematic review and meta-analysis |
| - | Review, | Var, | NA |
| 2150- | Ex, | Roles and molecular mechanisms of physical exercise in cancer prevention and treatment |
| - | Review, | Var, | NA |
| 2149- | Ex, | Physical activity and exercise training in cancer patients |
| - | Analysis, | Var, | NA |
| 4139- | Ex, | Impact of physical exercise on the regulation of brain-derived neurotrophic factor in people with neurodegenerative diseases |
| - | Review, | AD, | NA |
| 4141- | Ex, | Effects of exercise on brain-derived neurotrophic factor in Alzheimer's disease models: A systematic review and meta-analysis |
| - | Review, | AD, | NA |
| 4143- | Ex, | Brain-Derived Neurotrophic Factor: A Connecting Link Between Nutrition, Lifestyle, and Alzheimer’s Disease |
| - | Review, | AD, | NA |
| 4145- | Ex, | Effects of different physical activities on brain-derived neurotrophic factor: A systematic review and bayesian network meta-analysis |
| - | Review, | AD, | NA |
| 5061- | Ex, | Role of physical exercise in modulating the insulin-like growth factor system for improving breast cancer outcomes: A meta-analysis |
| - | Review, | BC, | NA |
| 5235- | Ex, | Effect of Low-Intensity Aerobic Exercise on Insulin-Like Growth Factor-I and Insulin-Like Growth Factor-Binding Proteins in Healthy Men |
| - | Trial, | Nor, | NA |
| 1622- | FA, | Folate and Its Impact on Cancer Risk |
| - | Review, | NA, | NA |
| 1654- | FA, | Molecular mechanism of ferulic acid and its derivatives in tumor progression |
| - | Review, | Var, | NA |
| 2173- | FA, | VitB12, | Elevated serum homocysteine levels associated with poor recurrence-free and overall survival in patients with colorectal cancer |
| - | Study, | CRC, | NA |
| 2174- | FA, | VitB12, |
| - | Analysis, | Var, | NA |
| 2176- | FA, | VitB12, | Hyperhomocysteinemia and Cancer: The Role of Natural Products and Nutritional Interventions |
| - | Review, | Var, | NA |
| 4069- | FA, | Folate, folic acid and 5-methyltetrahydrofolate are not the same thing |
| - | Review, | AD, | NA |
| 2499- | Fenb, | VitE, | Effects of fenbendazole and vitamin E succinate on the growth and survival of prostate cancer cells |
| - | in-vitro, | Pca, | PC3 |
| 2498- | Fenb, | Unexpected Antitumorigenic Effect of Fenbendazole when Combined with Supplementary Vitamins |
| - | in-vivo, | lymphoma, | NA |
| 2496- | Fenb, | Impairment of the Ubiquitin-Proteasome Pathway by Methyl N-(6-Phenylsulfanyl-1H-benzimidazol-2-yl)carbamate Leads to a Potent Cytotoxic Effect in Tumor Cells |
| - | in-vitro, | NSCLC, | A549 | - | in-vitro, | NSCLC, | H460 |
| 2494- | Fenb, | Oral Fenbendazole for Cancer Therapy in Humans and Animals |
| - | Review, | Var, | NA |
| 2495- | Fenb, | Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells |
| - | in-vitro, | Melanoma, | A375 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:961 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid